Alston & Bird Secures Litigation Win for Sandoz
November 16, 2024
November 16, 2024
ATLANTA, Georgia, Nov. 16 -- Alston and Bird, a law firm, issued the following news release:
On November 4, Alston & Bird secured over $70 million in damages for client Sandoz in litigation against biopharmaceutical firm United Therapeutics Corp. (UTC).
In 2019, Sandoz filed a suit alleging UTC blocked the sale of a generic version of hypertension medication by colluding with the manufacturer of infusion pumps for injecting UTC's brand-name hypertension drug Remodul . . .
On November 4, Alston & Bird secured over $70 million in damages for client Sandoz in litigation against biopharmaceutical firm United Therapeutics Corp. (UTC).
In 2019, Sandoz filed a suit alleging UTC blocked the sale of a generic version of hypertension medication by colluding with the manufacturer of infusion pumps for injecting UTC's brand-name hypertension drug Remodul . . .